PEDEVCO (NYSE: PED) insider sold 18,797 shares, plans more

Rhea-AI Filing Summary

PEDEVCO Corp. insider Clark Moore notified plans to sell 3,765 shares of common stock through broker Oppenheimer & Co., Inc. with an associated value of $48,229.65. These shares were acquired on 01/23/2023 as compensation from the issuer.

The filing also lists prior activity: on 06/30/2026, Moore sold 18,797 common shares with an aggregate value of $275,789.58, reported under “Securities Sold During The Past 3 Months.”

Key Figures

Shares planned for sale: 3,765 shares Associated value of planned sale: $48,229.65 Shares sold in prior 3 months: 18,797 shares +1 more

4 metrics

Shares planned for sale 3,765 shares Common stock listed under Securities To Be Sold

Associated value of planned sale $48,229.65 Value figure tied to 3,765 common shares with Oppenheimer & Co., Inc.

Shares sold in prior 3 months 18,797 shares Common stock under Securities Sold During The Past 3 Months on 06/30/2026

Value of prior 3‑month sales $275,789.58 Aggregate value for 18,797 common shares sold on 06/30/2026

Key Terms

Securities To Be Sold, Securities Sold During The Past 3 Months, Compensation

3 terms

Securities To Be Sold regulatory

"listed under “144: Securities To Be Sold” for common shares"

Securities Sold During The Past 3 Months regulatory

"shown in “144: Securities Sold During The Past 3 Months” section"

Compensation financial

"Common | 01/23/2023 | Compensation | Issuer"

FAQ

What insider share sale is disclosed for PED in this Form 144?

The filing reports that Clark Moore plans to sell 3,765 shares of PED common stock through Oppenheimer & Co., Inc., with an associated value of $48,229.65, and identifies the shares as compensation received from the issuer on 01/23/2023.

Which broker is handling the planned PED share sale for Clark Moore?

The planned sale of 3,765 PED common shares is associated with Oppenheimer & Co., Inc., located at 85 Broad St, New York, NY 10004, as listed in the securities information section of the Form 144 filing.

When were the PED shares to be sold by Clark Moore originally acquired?

The 3,765 PED common shares referenced in the Form 144 are shown as acquired on 01/23/2023 as compensation from the issuer, according to the securities information section describing their origin.

What PED stock sales in the past three months does the Form 144 report?

Under “Securities Sold During The Past 3 Months,” the filing shows that Clark Moore sold 18,797 PED common shares on 06/30/2026, with an aggregate value of $275,789.58, providing recent historical sale activity for this security holder.

What total share quantity is involved in Clark Moore’s current and recent PED transactions?

The Form 144 lists a planned sale of 3,765 PED common shares and a prior sale of 18,797 shares on 06/30/2026, giving visibility into the scale of Clark Moore’s recent and intended dispositions of PED common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:20 PM Accepted by SEC EDGAR 08/17/2026 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Oppenheimer & Co, Inc 85 Broad St New York NY 10004	3765	48229.65	13290902	08/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/23/2023	Compensation	Issuer			3765	01/23/2023	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Clark Moore 12244 SANTA TERESA DRIVE San Ramon CA 94538	Common	06/30/2026	18797	275789.58

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)